TrialAmerican journal of hematology2023
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
Nidhi Aggarwal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it